As part of the Baby-OSCAR Trial, parents will be contacted when their child(ren) reach(es) 2 years of age to complete a questionnaire about their child(ren)'s health and development. This will help us get a better picture of the study results.
Many trials will include an element of long-term follow-up; It is just as important to record the long-term effects as it is the immediate results following treatment.
By completing this long-term follow-up, the researchers can spot any long-term benefits to the treatments received, and also monitor any long-term negative outcomes. The conclusions of one such study demonstrate the importance of this follow-up stage in gaining the bigger picture for study results and how these follow-up developmental assessments can provide key information for future treatments and further trials. The results have been published in the following paper: Neurodevelopmental Outcome at 2 Years of Age according to Patent Ductus Arteriosus Management in Very Preterm Infants; Bourgoin, L. et al (Neonatology, 2016). You can read more about it by clicking on the link below.